These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 36454533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
    Namwat N, Puetkasichonpasutha J, Loilome W, Yongvanit P, Techasen A, Puapairoj A, Sripa B, Tassaneeyakul W, Khuntikeo N, Wongkham S.
    J Gastroenterol; 2011 May; 46(5):664-75. PubMed ID: 21076843
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, Jiang H, Lu J, Sun X.
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J, Zou S.
    BMC Cancer; 2014 Dec 05; 14():917. PubMed ID: 25479763
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
    Huang Q, Liu L, Liu CH, You H, Shao F, Xie F, Lin XS, Hu SY, Zhang CH.
    Asian Pac J Cancer Prev; 2013 Dec 05; 14(2):829-34. PubMed ID: 23621247
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B, Hu Y, Qin L, Peng XB, Huang YX.
    Dig Liver Dis; 2019 Mar 05; 51(3):397-411. PubMed ID: 30314946
    [Abstract] [Full Text] [Related]

  • 7. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.
    Asukai K, Kawamoto K, Eguchi H, Konno M, Asai A, Iwagami Y, Yamada D, Asaoka T, Noda T, Wada H, Gotoh K, Nishida N, Satoh T, Doki Y, Mori M, Ishii H.
    Ann Surg Oncol; 2017 Aug 05; 24(8):2344-2352. PubMed ID: 28560603
    [Abstract] [Full Text] [Related]

  • 8. Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.
    Li L, Piontek K, Ishida M, Fausther M, Dranoff JA, Fu R, Mezey E, Gould SJ, Fordjour FK, Meltzer SJ, Sirica AE, Selaru FM.
    Hepatology; 2017 Feb 05; 65(2):501-514. PubMed ID: 27474881
    [Abstract] [Full Text] [Related]

  • 9. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
    Li D, Tang Z, Gao Z, Shen P, Liu Z, Dang X.
    Mol Cell Biol; 2020 Jul 14; 40(15):. PubMed ID: 32423991
    [Abstract] [Full Text] [Related]

  • 10. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F.
    Tumour Biol; 2016 Nov 14; 37(11):15019-15029. PubMed ID: 27658773
    [Abstract] [Full Text] [Related]

  • 11. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y, Liang H, Chen W, Zhang H, Wang N, Wang F, Zhang S, Liu Y, Zhao C, Yan X, Zhang J, Zhang CY, Gu H, Zen K, Chen X.
    RNA Biol; 2015 Nov 14; 12(3):276-89. PubMed ID: 25826661
    [Abstract] [Full Text] [Related]

  • 12. Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma.
    Ikeda C, Haga H, Makino N, Inuzuka T, Kurimoto A, Ueda T, Matsuda A, Kakizaki Y, Ishizawa T, Kobayashi T, Sugahara S, Tsunoda M, Suda K, Ueno Y.
    Sci Rep; 2021 Jan 13; 11(1):1195. PubMed ID: 33441949
    [Abstract] [Full Text] [Related]

  • 13. Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.
    Palladini G, Di Pasqua LG, Croce AC, Ferrigno A, Vairetti M.
    Int J Mol Sci; 2023 Dec 12; 24(24):. PubMed ID: 38139236
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.
    Chusorn P, Namwat N, Loilome W, Techasen A, Pairojkul C, Khuntikeo N, Dechakhamphu A, Talabnin C, Chan-On W, Ong CK, Teh BT, Yongvanit P.
    Tumour Biol; 2013 Jun 12; 34(3):1579-88. PubMed ID: 23417858
    [Abstract] [Full Text] [Related]

  • 15. Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1.
    Yuan Z, Xiong B, Liu L, Lu Y, Liu Y, Wang G, Qian Y, Diao B, Tu M.
    J Biochem Mol Toxicol; 2024 Feb 12; 38(2):e23656. PubMed ID: 38348717
    [Abstract] [Full Text] [Related]

  • 16. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers.
    Xu Y, Leng K, Yao Y, Kang P, Liao G, Han Y, Shi G, Ji D, Huang P, Zheng W, Li Z, Li J, Huang L, Yu L, Zhou Y, Jiang X, Wang H, Li C, Su Z, Tai S, Zhong X, Wang Z, Cui Y.
    Hepatology; 2021 Apr 12; 73(4):1419-1435. PubMed ID: 32750152
    [Abstract] [Full Text] [Related]

  • 17. Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.
    Li Y, Zhang Y, Zheng Q.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Apr 12; 25(5):552-4. PubMed ID: 16463672
    [Abstract] [Full Text] [Related]

  • 18. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z, Ma J.
    Cancer Biomark; 2019 Apr 12; 24(2):173-181. PubMed ID: 30594918
    [Abstract] [Full Text] [Related]

  • 19. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ.
    World J Gastroenterol; 2014 Dec 14; 20(46):17439-47. PubMed ID: 25516656
    [Abstract] [Full Text] [Related]

  • 20. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
    Peng F, Jiang J, Yu Y, Tian R, Guo X, Li X, Shen M, Xu M, Zhu F, Shi C, Hu J, Wang M, Qin R.
    Br J Cancer; 2013 Dec 10; 109(12):3092-104. PubMed ID: 24169343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.